全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
Health  2023 

Uniphyline-Induced Hypophosphatemia: A Rare Etiology of Severe Respiratory Failure

DOI: 10.4236/health.2023.157052, PP. 810-813

Keywords: Hypophosphatemia, Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease, Uniphyline, Theophyline, Bronchodilator Therapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Hypophosphataemia is defined as low level of phosphate in the blood (normal range 0.8 - 1.4 mmol/l), which can be drug-induced such as uniphyline. We present a case of elderly female patient with known chronic obstructive pulmonary disease, admitted with acute respiratory failure and low serum phosphate level, her clinical signs and serum phosphate level did not improve with conventional therapy and intravenous phosphate replacement, until her recently commenced uniphyline was discontinued. This highlights the importance of awareness amongst the clinicians about this rare but potential side effect of uniphyline. We suggest monitoring phosphate levels in patients admitted with acute respiratory failure especially those on extended bronchodilator therapy.

References

[1]  Megapanou, E., Florentin, M., Milionis, H., Elisaf, M. and Liamis, G. (2020) Drug-Induced Hypophosphatemia: Current Insights. Drug Safety, 43, 197-210.
https://doi.org/10.1007/s40264-019-00888-1
[2]  Liamis, G., Milionis, H.J. and Elisaf, M. (2010) Medication-Induced Hypophosphatemia: A Review. QJM: An International Journal of Medicine, 103, 449-459.
https://doi.org/10.1093/qjmed/hcq039
[3]  Gallo de Moraes, A. and Surani, S. (2019) Effects of Diabetic Ketoacidosis in the Respiratory System. World Journal of Diabetes, 10, 16-22.
https://doi.org/10.4239/wjd.v10.i1.16
[4]  Brady, H.R., Ryan, F., Cunningham, J., Tormey, W., Ryan, M.P. and O’Neill, S. (1989) Hypophosphatemia Complicating Bronchodilator Therapy for Acute Severe Asthma. Arch Internal Medicine, 149, 2367-2368.
https://doi.org/10.1001/archinte.149.10.2367
[5]  Christov, M. and Juppner, H. (2018) Phosphate Homeostasis Disorders. Best Practice & Research Clinical Endocrinology & Metabolism, 32, 685-706.
https://doi.org/10.1016/j.beem.2018.06.004
[6]  Lederer, E. and Wagner, C.A. (2019) Clinical Aspects of the Phosphate Transporters NaPi-IIa and NaPi-IIb: Mutations and Disease Associations. Pflugers Archiv—European Journal of Physiology, 471, 137-148.
https://doi.org/10.1007/s00424-018-2246-5
[7]  Charron, T., Bernard, F., Skrobik, Y., Simoneau, N., Gagnon, N. and Leblanc, M. (2003) Intravenous Phosphate in the Intensive Care Unit: More Aggressive Repletion Regimens for Moderate and Severe Hypophosphatemia. Intensive Care Medicine, 29, 1273-1278.
https://doi.org/10.1007/s00134-003-1872-2

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133